Finance

Lists
KAEF:IDX
Kimia Farma (Persero) Tbk PT
438,00 IDR
-1,79%
(-8,00) 1D
8 ოქტ, 09:43:04 GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for KAEF...
Open
446 IDR
High
450 IDR
Low
438 IDR
Mkt. cap
2,42 ტრლ.
Avg. vol.
3,91 მლნ.
Volume
652,60 ათ.
52-wk high
785 IDR
52-wk low
380 IDR
EPS
-77 IDR
Shares outstanding
5,57 მლრდ.
No. of employees
9 ათ.
Open
446 IDR
High
450 IDR
Low
438 IDR
Mkt. cap
2,42 ტრლ.
Avg. vol.
3,91 მლნ.
Volume
652,60 ათ.
52-wk high
785 IDR
52-wk low
380 IDR
EPS
-77 IDR
Shares outstanding
5,57 მლრდ.
No. of employees
9 ათ.
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
1 საათის წინ
How Trial Enrollment Completion At Pulse Biosciences (PLSE) Has Changed Its Investment Story
Seeking Alpha
Seeking Alpha
·
33 წუთის წინ
What Happened To The Banks
Mitrade
Mitrade
·
56 წუთის წინ
Strip Out AI and the S&P 500 Looks Very Different, Goldman Index Shows
Investor's Business Daily
Investor's Business Daily
·
2 საათის წინ
Futures: Memory Giant's Earnings Surge, But Miss Views
Profile
PT Kimia Farma Tbk is an Indonesian pharmaceutical producer and distributor in Indonesia. It is based in Jakarta. Wikipedia
About Kimia Farma (Persero) Tbk PT
CEO-
Employees9,36 ათ.
Founded16 აგვ. 1971
Headquarters-
SectorPharmaceutical industry
Websitekimiafarma.co.id
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
2,64 ტრლ.
2,22 ტრლ.
2,03 ტრლ.
2,67 ტრლ.
Cost of goods sold
1,85 ტრლ.
1,56 ტრლ.
1,29 ტრლ.
1,86 ტრლ.
Cost of revenue
1,85 ტრლ.
1,56 ტრლ.
1,29 ტრლ.
1,86 ტრლ.
Research and development expenses
5,03 მლრდ.
7,54 მლრდ.
3,20 მლრდ.
10,39 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
709,79 მლრ.
663,87 მლრ.
640,94 მლრ.
620,33 მლრ.
Operating expense
766,80 მლრ.
877,17 მლრ.
669,20 მლრ.
722,39 მლრ.
Total operating expenses
2,62 ტრლ.
2,44 ტრლ.
1,96 ტრლ.
2,59 ტრლ.
Operating income
23,59 მლრდ.
-222,99 მლრ.
67,93 მლრდ.
84,77 მლრდ.
Other non operating income
-2,92 მლრდ.
173,66 მლრ.
159,00 მლრ.
-26,56 მლრდ.
EBT including unusual items
-94,33 მლრდ.
-223,75 მლრ.
127,96 მლრ.
-60,16 მლრდ.
EBT excluding unusual items
-93,48 მლრდ.
-260,76 მლრ.
127,95 მლრ.
-60,19 მლრდ.
Income tax expense
4,17 მლრდ.
-14,50 მლრდ.
4,32 მლრდ.
9,40 მლრდ.
Effective tax rate
-4,42%
6,48%
3,37%
-15,62%
Other operating expenses
-37,43 მლრდ.
-36,20 მლრდ.
-12,78 მლრდ.
-9,74 მლრდ.
Net income
-84,72 მლრდ.
-155,23 მლრ.
74,45 მლრდ.
-64,12 მლრდ.
Net profit margin
-3,21%
-7,01%
3,67%
-2,40%
Earnings per share
-
-
-
-
Interest and investment income
2,65 მლრდ.
10,77 მლრდ.
2,87 მლრდ.
8,13 მლრდ.
Interest expense
-115,65 მლრ.
-221,53 მლრ.
-110,15 მლრ.
-125,81 მლრ.
Net interest expenses
-112,99 მლრ.
-210,75 მლრ.
-107,28 მლრ.
-117,68 მლრ.
Depreciation and amortization charges
89,41 მლრდ.
175,98 მლრ.
37,85 მლრდ.
101,42 მლრ.
EBITDA
105,34 მლრ.
-86,40 მლრდ.
125,64 მლრ.
165,62 მლრ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები